Relative to its peers, XTLB does not have very much institutional sponsorship. The 0.89% of shares outstanding held by institutional investors is among the least of any stock in the Biotechnology industry.
Mutual fund holders | 0.66% |
Other institutional | 0.22% |
Individual stakeholders | -- |